Zynex ROE 2010-2025 | ZYXI

Current and historical return on equity (ROE) values for Zynex (ZYXI) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Zynex ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2025-03-31 $-0.01B $0.02B -25.40%
2024-12-31 $0.00B $0.04B 5.80%
2024-09-30 $0.00B $0.04B 10.81%
2024-06-30 $0.01B $0.03B 14.04%
2024-03-31 $0.01B $0.03B 16.00%
2023-12-31 $0.01B $0.05B 17.32%
2023-09-30 $0.02B $0.06B 25.50%
2023-06-30 $0.02B $0.06B 26.46%
2023-03-31 $0.02B $0.06B 25.76%
2022-12-31 $0.02B $0.07B 23.19%
2022-09-30 $0.02B $0.07B 25.35%
2022-06-30 $0.02B $0.07B 26.95%
2022-03-31 $0.02B $0.08B 28.15%
2021-12-31 $0.02B $0.07B 27.20%
2021-09-30 $0.01B $0.06B 17.17%
2021-06-30 $0.01B $0.06B 8.93%
2021-03-31 $0.01B $0.06B 10.31%
2020-12-31 $0.01B $0.06B 22.36%
2020-09-30 $0.01B $0.05B 32.26%
2020-06-30 $0.01B $0.03B 51.16%
2020-03-31 $0.01B $0.02B 54.79%
2019-12-31 $0.01B $0.02B 58.06%
2019-09-30 $0.01B $0.02B 70.59%
2019-06-30 $0.01B $0.01B 90.91%
2019-03-31 $0.01B $0.01B 105.26%
2018-12-31 $0.01B $0.01B 129.03%
2018-09-30 $0.01B $0.01B 148.15%
2018-06-30 $0.01B $0.01B 180.00%
2018-03-31 $0.01B $0.01B 360.00%
2017-12-31 $0.01B $0.01B 1400.00%
2017-09-30 $0.00B $0.00B -228.57%
2017-06-30 $0.00B $0.00B -92.31%
2017-03-31 $0.00B $0.00B -25.00%
2016-12-31 $0.00B $0.00B -23.53%
2016-09-30 $0.00B $0.00B 0.00%
2016-06-30 $0.00B $-0.01B 25.00%
2016-03-31 $0.00B $0.00B 28.57%
2015-12-31 $0.00B $0.00B 66.67%
2015-09-30 $0.00B $0.00B 0.00%
2015-06-30 $0.00B $0.00B 0.00%
2015-03-31 $-0.01B $0.00B 342.86%
2014-12-31 $-0.01B $0.00B 1200.00%
2014-09-30 $-0.01B $0.00B -1200.00%
2014-06-30 $-0.01B $0.00B -346.67%
2014-03-31 $-0.01B $0.00B -133.33%
2013-12-31 $-0.01B $0.01B -88.89%
2013-09-30 $0.00B $0.01B -27.91%
2013-06-30 $0.00B $0.01B -17.39%
2013-03-31 $0.00B $0.01B 0.00%
2012-12-31 $0.00B $0.01B 0.00%
2012-09-30 $0.00B $0.01B 9.09%
2012-06-30 $0.00B $0.01B 19.51%
2012-03-31 $0.00B $0.01B 20.51%
2011-12-31 $0.00B $0.01B 22.22%
2011-09-30 $0.00B $0.01B 11.76%
2011-06-30 $0.00B $0.01B 0.00%
2011-03-31 $0.00B $0.01B 0.00%
2010-12-31 $0.00B $0.01B 0.00%
2010-09-30 $0.00B $0.01B 0.00%
2010-06-30 $0.00B $0.01B 0.00%
2010-03-31 $0.00B $0.01B 14.81%
2009-12-31 $0.00B $0.01B 32.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.064B $0.192B
Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $235.957B 28.37
Boston Scientific (BSX) United States $147.560B 36.94
Stryker (SYK) United States $144.011B 30.11
EssilorLuxottica (ESLOY) France $127.141B 0.00
Medtronic (MDT) Ireland $111.928B 15.87
Lonza Group Ag (LZAGY) Switzerland $50.371B 0.00
Haleon (HLN) United Kingdom $48.926B 27.87
ResMed (RMD) United States $36.560B 27.46
Agilent Technologies (A) United States $33.258B 21.68
GE HealthCare Technologies (GEHC) United States $33.082B 15.71
Terumo (TRUMY) Japan $26.680B 34.65
Insulet (PODD) United States $21.438B 84.15
Koninklijke Philips (PHG) Netherlands $21.384B 15.37
Zimmer Biomet Holdings (ZBH) United States $18.060B 11.60
Baxter (BAX) United States $15.713B 11.73
Smith & Nephew SNATS (SNN) United Kingdom $12.872B 0.00
Demant (WILYY) Denmark $9.377B 0.00
Sunny Optical Technology (SNPTF) China $9.076B 0.00
Bio-Rad Laboratories (BIO) United States $6.175B 21.49
Lantheus Holdings (LNTH) United States $5.385B 13.58
Prestige Consumer Healthcare (PBH) United States $4.149B 18.54
Perrigo (PRGO) Ireland $3.664B 9.29
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.367B 15.34
ICU Medical (ICUI) United States $3.250B 23.96
Envista Holdings (NVST) United States $3.127B 25.99
QuidelOrtho (QDEL) United States $1.954B 13.44
LeMaitre Vascular (LMAT) United States $1.833B 40.97
AtriCure (ATRC) United States $1.565B 0.00
Acuren (TIC) United States $1.357B 0.00
Neogen (NEOG) United States $1.200B 15.36
AdaptHealth (AHCO) United States $1.161B 11.78
Green Thumb Industries (GTBIF) United States $1.048B 23.58
BioLife Solutions (BLFS) United States $1.046B 0.00
Phibro Animal Health (PAHC) United States $0.970B 12.40
Kestra Medical Technologies (KMTS) United States $0.904B 0.00
InMode (INMD) Israel $0.844B 8.51
Evolus (EOLS) United States $0.640B 0.00
CeriBell (CBLL) United States $0.624B 0.00
Owens & Minor (OMI) United States $0.602B 4.99
Maravai LifeSciences Holdings (MRVI) United States $0.542B 0.00
Capricor Therapeutics (CAPR) United States $0.538B 0.00
Curaleaf Holdings (CURLF) Canada $0.524B 0.00
Valneva SE (VALN) France $0.510B 0.00
Surmodics (SRDX) United States $0.417B 0.00
Tilray Brands (TLRY) Canada $0.407B 0.00
SNDL (SNDL) Canada $0.339B 0.00
VAREX IMAGING (VREX) United States $0.337B 12.41
SEMPERIT AG HLD (SEIGY) Austria $0.329B 0.00
Aurora Cannabis (ACB) Canada $0.329B 58.50
Canopy Growth (CGC) Canada $0.272B 0.00
Viemed Healthcare (VMD) United States $0.263B 22.17
Sanara MedTech (SMTI) United States $0.256B 0.00
Sanuwave Health (SNWV) United States $0.254B 0.00
ZimVie (ZIMV) United States $0.253B 11.52
Cerus (CERS) United States $0.252B 0.00
Cresco Labs (CRLBF) United States $0.245B 0.00
Quanterix (QTRX) United States $0.235B 0.00
OraSure Technologies (OSUR) United States $0.221B 0.00
Biote (BTMD) United States $0.207B 5.82
Brainsway (BWAY) Israel $0.206B 54.50
Omeros (OMER) United States $0.199B 0.00
TriSalus Life Sciences (TLSI) United States $0.196B 0.00
Organigram Global (OGI) Canada $0.187B 0.00
High Tide (HITI) Canada $0.185B 0.00
Utah Medical Products (UTMD) United States $0.179B 14.59
Verano Holdings (VRNOF) United States $0.174B 0.00
Exagen (XGN) United States $0.152B 0.00
Vireo Growth (VREOF) United States $0.140B 0.00
FitLife Brands (FTLF) United States $0.131B 16.18
Jin Medical (ZJYL) China $0.107B 0.00
MacroGenics (MGNX) United States $0.096B 0.00
Fonar (FONR) United States $0.090B 11.64
Veru (VERU) United States $0.090B 0.00
Quipt Home Medical (QIPT) United States $0.087B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Agape ATP (ATPC) $0.084B 0.00
TerrAscend (TSNDF) Canada $0.075B 0.00
Cytosorbents (CTSO) United States $0.068B 0.00
InterCure (INCR) Israel $0.068B 0.00
Apyx Medical (APYX) United States $0.066B 0.00
ImmuCell (ICCC) United States $0.059B 0.00
Jushi Holdings (JUSHF) United States $0.054B 0.00
Modular Medical (MODD) United States $0.042B 0.00
Nephros (NEPH) United States $0.041B 55.29
United-Guardian (UG) United States $0.037B 12.90
Rockwell Medical (RMTI) United States $0.032B 0.00
Cellectar Biosciences (CLRB) United States $0.019B 0.00
Allurion Technologies (ALUR) United States $0.019B 0.00
Safety Shot (SHOT) United States $0.018B 0.00
Flora Growth (FLGC) United States $0.017B 0.00
INLIF (INLF) $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.011B 0.00
Meihua Medical Technologies (MHUA) China $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.008B 0.00
Senestech (SNES) United States $0.006B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00